Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.880
+0.030 (1.62%)
Mar 6, 2026, 4:00 PM EST - Market closed
CELZ Market Cap
CELZ has a market cap or net worth of $6.57 million as of March 6, 2026. Its market cap has decreased by -37.43% in one year.
Market Cap
6.57M
Enterprise Value
1.21M
1-Year Change
-37.43%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $6.57M, a decrease of -59.19%. That is a compound annual growth rate of -18.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.90M | -3.92% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 6.85M |
| Moolec Science | 6.83M |
| XTL Biopharmaceuticals | 6.73M |
| Aspire Biopharma Holdings | 6.58M |
| Theriva Biologics | 6.58M |
| Aptorum Group | 6.52M |
| Immuron | 6.46M |
| Processa Pharmaceuticals | 6.46M |